Yoshiaki Kuroda

Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7

Jiro Kikuchi, Mitsuo Hori, Hidekatsu Iha et al. · Leukemia · 2019 · 67 citations

Life Sciences, Immunology, Molecular Biology +7

Clinical Significance of sIL-2R Levels in B-Cell Lymphomas

Noriaki Yoshida, Miyo Oda, Yoshiaki Kuroda et al. · PLoS ONE · 2013 · 59 citations · Full text

Medicine, Hematology, Immunology +17

Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation

Shuji Ozaki, Takeshi Harada, Takayuki Saitoh et al. · Acta Haematologica · 2014 · 52 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Osteoprogenitor differentiation is not affected by immunomodulatory thalidomide analogs but is promoted by low bortezomib concentration, while both agents suppress osteoclast differentiation

Shoso Munemasa, Akira Sakai, Yoshiaki Kuroda et al. · International Journal of Oncology · 2008 · 42 citations · Full text

Medicine, Oncology, Pharmacology +15

Iterative Decomposition of Water and Fat with Echo Asymmetry and Least-Squares Estimation (IDEAL) Magnetic Resonance Imaging as a Biomarker for Symptomatic Multiple Myeloma

Miyuki Takasu, Yoko Kaichi, Chihiro Tani et al. · PLoS ONE · 2015 · 35 citations · Full text

Medicine, Oncology, Radiology +17